Feed ELAN
Market cap
$11.6B
Enterprise value
$15.0B
P/E
-
Forward P/E
20.2x
PEG
-
P/S
2.3x
P/FCF
30.6x
EV/EBITDA
19.4x
ROIC
4.7%
Gross margin
52.6%
Net margin
-4.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
4.4x
Beta
1.71
Free float
99.0%

About the company

Elanco Animal Health Incorporated (ELAN) is an American pharmaceutical company specializing in research, development, and manufacturing of veterinary medicines and products for animal health. The company focuses on providing innovative therapeutic and preventive solutions for various types of animals, including pets, livestock, and companion animals. Elanco Animal Health offers a wide range of veterinary medicines and supplementary products that help improve animal health and well-being, as well as increase productivity and efficiency in agriculture. The company emphasizes scientific research and innovation to meet the needs of veterinary care worldwide. Elanco Animal Health Incorporated is recognized as a reliable partner for veterinarians, breeders, and farmers. Elanco Animal Health Incorporated (ELAN) shares may represent an attractive investment opportunity for investors monitoring the animal-focused pharmaceutical sector and seeking investments in a company with a positive impact on animal health and agricultural productivity.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Jeffrey N. Simmons

Employees

9,650

Headquarters

Indianapolis

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: It beat profit estimates 7 times in the last 8 quarters.
  • What to watch: Revenue grew by only 2.2% a year over the last 3 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: Operating profit does not even cover the interest on its debt.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy